Evidence-Based Treatment

The Benefits of Medication-Assisted Treatment (MAT) for Opioid Addiction

Jim Rosson, FNP-C
December 15, 2024
12 min read

Medication-Assisted Treatment (MAT) represents the gold standard for treating opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. This evidence-based approach has helped millions of people achieve and maintain recovery from opioid addiction.

Understanding Medication-Assisted Treatment

Medication-Assisted Treatment is a comprehensive approach to treating opioid use disorder that uses FDA-approved medications alongside counseling and behavioral therapies. MAT is not simply replacing one drug with another—it's a clinically proven treatment that normalizes brain chemistry, blocks the euphoric effects of opioids, relieves physiological cravings, and normalizes body functions without the negative effects of the abused drug.

The Substance Abuse and Mental Health Services Administration (SAMHSA) and leading medical organizations recognize MAT as the most effective treatment for opioid use disorder. Research consistently shows that MAT significantly improves survival rates, increases retention in treatment, decreases illicit opioid use, and increases patients' ability to maintain employment and stable housing.

The Science Behind MAT

Opioid addiction is a chronic brain disease, not a moral failing or lack of willpower. Opioids change the brain's chemistry, creating powerful physical dependence. MAT medications work by targeting the same brain receptors as opioids, but in a controlled, therapeutic way that allows the brain to heal while preventing withdrawal and cravings.

The Three Pillars of MAT

Effective MAT programs rest on three essential components:

1. FDA-Approved Medications

Three medications are FDA-approved for treating opioid use disorder. Each works differently and may be appropriate for different individuals:

Buprenorphine (Suboxone, Subutex)

How it works: A partial opioid agonist that reduces cravings and withdrawal symptoms without producing the euphoric high of full opioid agonists. It has a "ceiling effect," meaning that after a certain dose, increasing the amount doesn't increase the effects, making it safer than full agonists.

Administration: Typically taken as a daily sublingual film or tablet that dissolves under the tongue. Long-acting injectable forms (Sublocade) and implants (Probuphine) are also available.

Benefits: Can be prescribed in an office setting by certified providers, offers flexibility in dosing, lower risk of misuse compared to methadone, allows patients to take medication at home, suitable for various stages of recovery.

Methadone (Dolophine, Methadose)

How it works: A full opioid agonist that reduces cravings and withdrawal symptoms by activating opioid receptors in the brain. When taken as prescribed, it doesn't produce a high and helps normalize brain function.

Administration: Must be dispensed through certified opioid treatment programs (OTPs) or methadone clinics. Patients typically start with daily supervised dosing and may earn take-home privileges over time.

Benefits: Longest track record of effectiveness (over 50 years), effective for severe opioid use disorder, provides structured support through daily clinic visits initially, reduces mortality and increases retention in treatment.

Naltrexone (Vivitrol)

How it works: An opioid antagonist that blocks opioid receptors in the brain, preventing opioids from producing rewarding effects. It doesn't relieve cravings or withdrawal symptoms but prevents relapse by blocking the effects if someone uses opioids.

Administration: Available as a daily oral tablet or monthly injection (Vivitrol). The injectable form ensures medication adherence and eliminates the need for daily dosing.

Benefits: No potential for misuse or diversion, no physical dependence, can be prescribed by any licensed healthcare provider, monthly injection option improves adherence, suitable for motivated patients who have completed detoxification.

Important Note About Naltrexone

Naltrexone can only be started after complete detoxification from opioids (typically 7-10 days after last opioid use). Starting naltrexone too soon can cause severe precipitated withdrawal. This requirement makes naltrexone less suitable for some patients, but it's an excellent option for those who have already completed detox and are highly motivated to maintain abstinence.

2. Counseling and Behavioral Therapies

Medication alone is not enough—counseling is a crucial component of MAT. Evidence-based therapies help patients address the psychological, social, and behavioral aspects of addiction:

  • Cognitive Behavioral Therapy (CBT): Helps identify and change thought patterns and behaviors related to substance use
  • Motivational Enhancement Therapy: Strengthens personal motivation and commitment to change
  • Contingency Management: Uses positive reinforcement to encourage abstinence and treatment participation
  • Group Therapy: Provides peer support and helps develop healthy social connections
  • Family Therapy: Addresses family dynamics and helps rebuild relationships damaged by addiction
  • Individual Counseling: Provides personalized support for co-occurring mental health issues, trauma, and personal challenges

3. Comprehensive Support Services

Effective MAT programs provide wraparound services that address the full range of patient needs:

  • Medical care for co-occurring health conditions
  • Mental health treatment for depression, anxiety, PTSD, and other disorders
  • Case management and care coordination
  • Assistance with housing, employment, and legal issues
  • Support groups and peer recovery services
  • Family education and support
  • Life skills training and educational support

The Proven Benefits of MAT

Decades of research have demonstrated that MAT is the most effective treatment for opioid use disorder:

Saves Lives

MAT reduces the risk of fatal overdose by more than 50%. Studies show that people who receive MAT are significantly less likely to die from overdose compared to those who attempt abstinence-only approaches.

Increases Treatment Retention

Patients receiving MAT stay in treatment longer than those who don't receive medication. Studies show retention rates of 60-90% for MAT patients compared to 40-60% for medication-free treatment programs. Staying in treatment is one of the strongest predictors of long-term recovery.

Reduces Illicit Drug Use

MAT significantly decreases the use of heroin, fentanyl, and other illicit opioids. By eliminating withdrawal symptoms and reducing cravings, MAT allows patients to focus on recovery without the constant physical need for drugs.

Improves Social Functioning

Patients on MAT show improved employment rates, better family relationships, decreased criminal activity, and enhanced overall quality of life. By stabilizing brain chemistry, MAT allows people to focus on rebuilding their lives.

Reduces HIV and Hepatitis C Transmission

By reducing injection drug use, MAT significantly decreases the transmission of bloodborne diseases like HIV and hepatitis C. This benefits not just individual patients but public health overall.

Improves Outcomes for Pregnant Women

MAT is the standard of care for pregnant women with opioid use disorder. It reduces the risk of miscarriage, premature birth, and other complications. Babies born to mothers on MAT do better than those whose mothers used illicit opioids or attempted unsupervised withdrawal.

Cost-Effective

MAT reduces healthcare costs, criminal justice expenses, and other societal costs associated with opioid addiction. For every dollar spent on MAT, society saves approximately $4-12 in reduced crime, healthcare, and other costs.

Addressing Common Misconceptions About MAT

Despite overwhelming evidence supporting MAT, misconceptions persist. Let's address the most common myths:

Myth: "MAT is just replacing one addiction with another"

Reality: This is perhaps the most harmful misconception about MAT. Addiction is defined by compulsive drug seeking and use despite harmful consequences. MAT medications, when taken as prescribed, do not produce euphoria or impairment. They allow the brain to heal and help people regain control of their lives—the opposite of addiction.

Compare it to other medications: We don't say that people with diabetes are "addicted" to insulin or that people with high blood pressure are "addicted" to blood pressure medication. MAT medications are prescribed treatments for a chronic medical condition.

Myth: "People on MAT aren't really in recovery"

Reality: Recovery is about regaining health and well-being, not about being medication-free. People who take MAT medications and aren't using illicit drugs are absolutely in recovery. They're working, caring for their families, and living productive lives—the essence of recovery. The recovery community increasingly recognizes medication-assisted recovery as valid and successful recovery.

Myth: "MAT should only be short-term"

Reality: Opioid use disorder is a chronic condition, and many people benefit from long-term or even lifelong MAT. The idea that people must taper off medication to be "successful" ignores the medical reality of addiction. Research shows that people who stay on MAT longer have better outcomes. The decision about duration should be made collaboratively between patient and provider based on individual circumstances, not arbitrary timelines.

Myth: "MAT medications are too easy to get"

Reality: Actually, the opposite is often true. Many people who would benefit from MAT face significant barriers to accessing treatment, including limited provider availability, insurance restrictions, lack of transportation, and stigma. Making evidence-based treatment more accessible saves lives and should be a public health priority.

Myth: "Willpower and abstinence-only approaches work better than MAT"

Reality: While some people achieve recovery through abstinence-only approaches, the research is clear that MAT produces better outcomes for the majority of people with opioid use disorder. Abstinence-only approaches have much higher dropout and relapse rates. For opioid addiction, MAT is the evidence-based standard of care recommended by every major medical organization.

Who Can Benefit from MAT?

MAT is recommended for anyone with opioid use disorder, which is diagnosed when someone experiences at least two of the following within a 12-month period:

  • Using opioids in larger amounts or for longer than intended
  • Persistent desire or unsuccessful efforts to cut down or control use
  • Spending significant time obtaining, using, or recovering from opioids
  • Craving or strong desire to use opioids
  • Failure to fulfill major role obligations at work, school, or home due to use
  • Continued use despite persistent social or interpersonal problems
  • Giving up important activities because of opioid use
  • Using opioids in physically hazardous situations
  • Continued use despite knowing it causes or worsens physical or psychological problems
  • Tolerance (needing more to achieve the same effect)
  • Withdrawal symptoms when stopping or reducing use

MAT may be particularly beneficial for college students and young adults because it allows them to continue their education and build their careers while in treatment. The stability provided by MAT makes it possible to attend classes, maintain employment, and focus on personal growth.

What to Expect When Starting MAT

Initial Assessment

Your MAT journey begins with a comprehensive assessment by a qualified healthcare provider. This includes:

  • Complete medical and substance use history
  • Mental health screening
  • Physical examination
  • Discussion of treatment goals and medication options
  • Development of a comprehensive treatment plan

Medication Induction

Starting MAT medication requires careful management to ensure safety and effectiveness:

  • Buprenorphine: Typically started when you're experiencing mild withdrawal (usually 12-24 hours after last opioid use). The first dose is given in the provider's office to monitor your response and adjust the dose as needed.
  • Methadone: Started at a low dose at an opioid treatment program, with daily supervised dosing. The dose is gradually increased until withdrawal symptoms and cravings are controlled.
  • Naltrexone: Requires complete detoxification first (7-10 days opioid-free). A naloxone challenge test may be performed to ensure all opioids have cleared your system before starting naltrexone.

Ongoing Treatment

Once stabilized on medication, your treatment will include:

  • Regular follow-up appointments with your prescriber
  • Individual and/or group counseling sessions
  • Urine drug testing to monitor progress
  • Medication dose adjustments as needed
  • Treatment for co-occurring medical and mental health conditions
  • Connection to recovery support services
  • Assistance with life skills, education, and employment

MAT for Texas Tech Students and Young Adults

For college students struggling with opioid addiction, MAT offers the stability needed to continue your education while addressing your substance use disorder. Here's what makes MAT particularly suitable for students:

  • Maintain Academic Progress: By eliminating withdrawal symptoms and cravings, MAT allows you to focus on your studies
  • Flexible Treatment Options: Buprenorphine can be prescribed in an office setting with take-home medication, making it compatible with class schedules
  • Confidentiality: Your treatment is protected by federal confidentiality regulations (42 CFR Part 2), and you don't have to disclose your treatment to your school
  • Evidence-Based Approach: MAT is recognized by student health services and disability services as appropriate medical treatment
  • Recovery Support: Treatment can be coordinated with campus counseling services and collegiate recovery programs
  • Long-Term Success: MAT provides the stability needed to complete your degree and launch your career

Privacy and Your Rights

Federal law (42 CFR Part 2) provides strong privacy protections for people receiving substance use disorder treatment. Your MAT provider cannot share information about your treatment with anyone— including family members, employers, or your school—without your written consent.

If you need accommodations at school due to treatment appointments, you can work with disability services to request reasonable accommodations without disclosing specific details about your treatment.

Finding MAT Services in Lubbock

At Lubbock Addiction Clinic, we provide comprehensive MAT services specifically designed for college students and young adults. Our approach includes:

  • Buprenorphine (Suboxone) treatment with certified providers
  • Individual counseling and therapy
  • Group therapy and peer support
  • Coordination with campus resources
  • Treatment for co-occurring mental health conditions
  • Family education and support
  • Flexible scheduling to accommodate class schedules
  • Long-term recovery support

We understand the unique challenges faced by college students and young adults in recovery. Our team is committed to providing compassionate, evidence-based care that supports both your recovery and your educational goals.

Taking the First Step

If you're struggling with opioid addiction, reaching out for help is a sign of strength, not weakness. MAT has helped millions of people reclaim their lives from opioid addiction. You don't have to face this alone, and you don't have to suffer through withdrawal or risk relapse trying to quit on your own.

Recovery is possible, and MAT provides a proven pathway to get there. Whether you're a Texas Tech student trying to stay in school while addressing your addiction, or someone in the Lubbock community seeking help for the first time, MAT can provide the foundation you need for lasting recovery.

Ready to Start Your Recovery Journey?

Don't wait another day to get the help you deserve. Our compassionate team at Lubbock Addiction Clinic is here to answer your questions about MAT and help you take the first step toward recovery.

All inquiries are confidential. We're available to speak with you about treatment options with no obligation.

About the Author

Jim Rosson, MSN, FNP-C - Family Nurse Practitioner at Lubbock Addiction Clinic

Jim Rosson, MSN, FNP-C

Board-Certified Family Nurse Practitioner | Addiction Management Specialist

Jim Rosson is a board-certified Family Nurse Practitioner with specialized expertise in addiction management and medication-assisted treatment. With years of clinical experience, Jim is dedicated to helping patients in Lubbock and across West Texas overcome opioid dependency through compassionate, evidence-based care.

5015 University Ave # B1, Lubbock, TX 79413

References & Additional Resources

  • • Substance Abuse and Mental Health Services Administration (SAMHSA) - TIP 63: Medications for Opioid Use Disorder
  • • National Institute on Drug Abuse (NIDA) - Effective Treatments for Opioid Addiction
  • • American Society of Addiction Medicine (ASAM) - National Practice Guideline for the Treatment of Opioid Use Disorder
  • • World Health Organization - Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence